Sunshine Act Meeting: Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 31780-31781 [2017-14515]
Download as PDF
31780
Federal Register / Vol. 82, No. 130 / Monday, July 10, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
business loans are published in the
quarterly E.2 statistical release, Survey
of Terms of Business Lending, and
aggregate estimates for farm loans are
published in the E.15 statistical release,
Agricultural Finance Databook.
Legal authorization and
confidentiality: The Board’s Legal
Division has determined that these
surveys are authorized by section
11(a)(2) of the Federal Reserve Act (12
U.S.C. 248(a)(2)) which authorizes the
Board to require any depository
institution to make such reports of its
assets and liabilities as the Board may
determine to be necessary or desirable
to enable the Board to discharge its
responsibility to monitor and control
monetary and credit aggregates. The
reports are voluntary. Individual
responses reported on the FR 2028A, FR
2028B, FR 2028D, and FR 2028S are
regarded as confidential under the
Freedom of Information Act (5 U.S.C.
552(b)(4)).
Current actions: On April 21, 2017,
the Board published a notice in the
Federal Register (82 FR 18759)
requesting public comment for 60 days
on the extension, with revision, of the
FR 2028. The Federal Reserve proposed
to (1) discontinue the FR 2028A, (2)
create a new Small Business Lending
Survey (FR 2028D) that would provide
focused and enhanced information on
small business lending including rates,
terms, credit availability, and reasons
for their changes (in contrast to the
individual loan data collected on the FR
2028A, the FR 2028D would collect
quarterly average quantitative data on
terms of small business loans and
qualitative information on changes and
the reasons for changes in the terms of
lending), and (3) rename the STL the
Survey of Small Business and Farm
Lending (SSBFL) to more accurately
describe the data collection. No changes
were proposed to the FR 2028B and FR
2028S. The comment period for this
notice expired on June 20, 2017. The
Board did not receive any comments.
The revisions will be implemented as
proposed.
Board of Governors of the Federal Reserve
System, July 5, 2017.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2017–14401 Filed 7–7–17; 8:45 am]
BILLING CODE 6210–01–P
VerDate Sep<11>2014
16:08 Jul 07, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Sunshine Act Meeting: Advisory
Council for the Elimination of
Tuberculosis Meeting (ACET)
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2017–14516 Filed 7–6–17; 4:15 pm]
10:00 a.m.–3:30 p.m.,
EDT, August 22, 2017
PLACE: Web conference. Toll free
number 1–877–927–1433, Participant
Code: 12016435, To join the meeting:
https://adobeconnect.cdc.gov/
r5p8l2tytpq/.
STATUS: In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention announces the meeting of
the ACET. This meeting is open to the
public. The meeting room
accommodates 100 ports. Persons who
desire to make an oral statement, may
request it at the time of the public
comment period on August 22, 2017 at
3:20p.m. EDT. Public participation and
ability to comment will be limited to
space and time as it permits.
MATTERS TO BE CONSIDERED: This council
advises and makes recommendations to
the Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis (TB).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis. Agenda items include the
following topics: (1) Update on making
latent tuberculosis infection (LTBI)
reportable from the Council of State and
Territorial Epidemiologists (CSTE)
meeting; (2) Update data on LTBI testing
and treatment from Aggregate Reports
for Tuberculosis Program Evaluation
(ARPE); (3) Update on CDC’s efforts to
transition to whole-genome sequencing;
(4) Updates from Workgroups; and (5)
other tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Margie Scott-Cseh, CDC, 1600 Clifton
Road NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
TIME AND DATE:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Sunshine Act Meeting: Advisory Board
on Radiation and Worker Health
(ABRWH or Advisory Board), National
Institute for Occupational Safety and
Health (NIOSH)
TIME/S/ AND DATE/S/:
8:15 a.m.–5:30 p.m., Mountain Time,
August 23, 2017
8:15 a.m.–4:30 p.m., Mountain Time,
August 24, 2017
PUBLIC COMMENT TIMES AND DATES: 5:30
p.m.–6:30 p.m., Mountain Time, August
23, 2017.
PLACE: Courtyard Marriott, 3347
Cerrillos Road, Santa Fe, New Mexico
87507; Phone: (505) 473–2800 Fax: (505)
473–5128.
STATUS: In accordance with section
10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the
aforementioned committee. This
meeting is Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people. Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 with a pass
code of 9933701. Skype Meeting
Connection: https://webconf.cdc.gov/
zab6/yzdq02pl?sl=1
MATTERS TO BE CONSIDERED: The
Advisory Board was established under
the Energy Employees Occupational
Illness Compensation Program Act of
2000 to advise the President on a variety
of policy and technical functions
required to implement and effectively
manage the new compensation program.
Key functions of the Advisory Board
include providing advice on the
development of probability of causation
guidelines which have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule, advice on methods of dose
reconstruction which have also been
E:\FR\FM\10JYN1.SGM
10JYN1
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 130 / Monday, July 10, 2017 / Notices
promulgated by HHS as a final rule,
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
This Advisory Board is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class.
The agenda for the Advisory Board
meeting includes: NIOSH Program
Update; Department of Labor Program
Update; Department of Energy Program
Update; SEC Petitions Update; Site
Profile reviews for Pantex Plant
(Amarillo, Texas), Pacific Proving
Grounds (Marshall Islands), Feed
Materials Production Center (Fernald,
Ohio), and possibly Nevada Test Site
(Mercury, Nevada); SEC petitions for:
Metals and Control Corp. (1968–1997;
Attleboro, Massachusetts), Los Alamos
National Laboratory (1996–2005; Los
Alamos, New Mexico), Idaho National
Laboratory (1970–1980; Scoville, Idaho),
Area IV of Santa Susanna Field
Laboratory (1991–1993; Ventura County,
California), Savannah River Site (1973–
2007; Aiken, South Carolina), and
possibly either Ames Laboratory (1971–
undetermined ending date; Ames, Iowa)
or Grand Junction Facilities (1986–2010;
Grand Junction, CO); and Board Work
Sessions.
The agenda is subject to change as
priorities dictate. In the event an
individual cannot attend, written
comments may be submitted to the
contact person below well in advance of
the meeting. Any written comments
received will be provided at the meeting
VerDate Sep<11>2014
16:08 Jul 07, 2017
Jkt 241001
in accordance with the redaction policy
provided below.
Policy on Redaction of Board Meeting
Transcripts (Public Comment):
(1) If a person making a comment
gives his or her personal information, no
attempt will be made to redact the
name; however, NIOSH will redact
other personally identifiable
information, such as contact
information, social security numbers,
case numbers, etc., of the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriate, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure. The Board will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
31781
Notice that announces Board and
Subcommittee meetings.
CONTACT PERSON FOR MORE INFORMATION:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30333,
telephone: (513)533–6800, toll free: 1–
800–CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–14515 Filed 7–6–17; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–3331]
Arthritis Advisory Committee; Notice
of Meeting; Establishment of a Public
Docket; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA or Agency)
announces a forthcoming public
advisory committee meeting of the
Arthritis Advisory Committee. The
general function of the committee is to
provide advice and recommendations to
the Agency on FDA’s regulatory issues.
The meeting will be open to the public.
FDA is establishing a docket for public
comment on this document.
DATES: The meeting will be held on
August 3, 2017, from 8 a.m. to 1 p.m.
ADDRESSES: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
FDA is establishing a docket for
public comment on this document. The
docket number is FDA–2017–N–3331.
SUMMARY:
E:\FR\FM\10JYN1.SGM
10JYN1
Agencies
[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Pages 31780-31781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14515]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Sunshine Act Meeting: Advisory Board on Radiation and Worker
Health (ABRWH or Advisory Board), National Institute for Occupational
Safety and Health (NIOSH)
Time/s/ and Date/s/:
8:15 a.m.-5:30 p.m., Mountain Time, August 23, 2017
8:15 a.m.-4:30 p.m., Mountain Time, August 24, 2017
Public Comment Times and Dates: 5:30 p.m.-6:30 p.m., Mountain Time,
August 23, 2017.
Place: Courtyard Marriott, 3347 Cerrillos Road, Santa Fe, New Mexico
87507; Phone: (505) 473-2800 Fax: (505) 473-5128.
Status: In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee. This meeting is Open to the public, limited only by the
space available. The meeting space accommodates approximately 100
people. Audio Conference Call via FTS Conferencing. The USA toll-free,
dial-in number is 1-866-659-0537 with a pass code of 9933701. Skype
Meeting Connection: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1
Matters to be Considered: The Advisory Board was established under the
Energy Employees Occupational Illness Compensation Program Act of 2000
to advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been
[[Page 31781]]
promulgated by HHS as a final rule, advice on the scientific validity
and quality of dose estimation and reconstruction efforts being
performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and will expire on September 30,
2017.
This Advisory Board is charged with (a) providing advice to the
Secretary, HHS, on the development of guidelines under Executive Order
13179; (b) providing advice to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction efforts performed for this
program; and (c) upon request by the Secretary, HHS, advising the
Secretary on whether there is a class of employees at any Department of
Energy facility who were exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and on whether there is
reasonable likelihood that such radiation doses may have endangered the
health of members of this class.
The agenda for the Advisory Board meeting includes: NIOSH Program
Update; Department of Labor Program Update; Department of Energy
Program Update; SEC Petitions Update; Site Profile reviews for Pantex
Plant (Amarillo, Texas), Pacific Proving Grounds (Marshall Islands),
Feed Materials Production Center (Fernald, Ohio), and possibly Nevada
Test Site (Mercury, Nevada); SEC petitions for: Metals and Control
Corp. (1968-1997; Attleboro, Massachusetts), Los Alamos National
Laboratory (1996-2005; Los Alamos, New Mexico), Idaho National
Laboratory (1970-1980; Scoville, Idaho), Area IV of Santa Susanna Field
Laboratory (1991-1993; Ventura County, California), Savannah River Site
(1973-2007; Aiken, South Carolina), and possibly either Ames Laboratory
(1971-undetermined ending date; Ames, Iowa) or Grand Junction
Facilities (1986-2010; Grand Junction, CO); and Board Work Sessions.
The agenda is subject to change as priorities dictate. In the event
an individual cannot attend, written comments may be submitted to the
contact person below well in advance of the meeting. Any written
comments received will be provided at the meeting in accordance with
the redaction policy provided below.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal
information, no attempt will be made to redact the name; however, NIOSH
will redact other personally identifiable information, such as contact
information, social security numbers, case numbers, etc., of the
commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriate, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure. The Board will take reasonable steps
to ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comments; (c) A statement such as outlined in
(a) above will also appear with the agenda for a Board Meeting when it
is posted on the NIOSH Web site; (d) A statement such as in (a) above
will appear in the Federal Register Notice that announces Board and
Subcommittee meetings.
Contact Person for More Information: Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, Georgia
30333, telephone: (513)533-6800, toll free: 1-800-CDC-INFO, email:
dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2017-14515 Filed 7-6-17; 4:15 pm]
BILLING CODE 4163-18-P